China News Agency, on the 18th that the “EpiVacCorona” coronavirus vaccine developed by the Russian “Vector” Virology and Biotechnology Research Center It will be put into civilian use before December 10.
Russian President Vladimir Putin announced on October 14 that the vaccine of the “Vector” Virology and Biotechnology Research Center has been registered in Russia, which is the second registered vaccine in Russia. According to reports, this vaccine has completed Phase I and Phase II clinical trials at the time of registration.
Golikova said that the vaccines put into civilian use before December 10 are “not many.” At present, the post-registration trial (referring to Phase III clinical trials) of the “EpiVacCorona” coronavirus vaccine has begun. On the 18th, the trial license was obtained from three institutions in Moscow and Moscow region. Tyumen, Kaliningrad and Tatarstan will also participate in the test on the 19th. A total of 3,000 people participated in the trial and it is scheduled to be completed on June 15, 2021.
Golikova mentioned that since the registration of Russia’s first coronavirus vaccine “Satellite-V”, 58,000 pieces have been produced for civilian use. The current production situation of the vaccine production platform is good, and the output is expected to have a huge increase. There will be 653,000 “satellite-V” vaccines for civilian use throughout November, and this number will increase to 2.2 million by December.
Putin said at the meeting that day that it currently takes 48 hours to detect the coronavirus. This time is too long and efforts need to be made to shorten the detection time. In addition, the amount of vaccines put into civilian use must be increased.
Putin mentioned that the pandemic situation in Russia is under control, and that the pandemic situation in certain regions is very serious. Judging from the figures, the number of people infected with the new coronavirus in Russia, the number of severely ill patients and the death rate have all increased.
